clinical trials

September 22, 2022 · Carlos Barrios, MD
In this “Cancer in My Community” post, Dr. Carlos Barrios discusses why he was drawn to oncology, the disparities that exist in cancer care in Brazil, why expanding access to clinical trials is so important, and resources available to help those with cancer in Brazil. Read More >>
September 14, 2022 · Manali I. Patel, MD, MPH, MS
Dr. Manali I. Patel discusses what people with cancer should know about getting access to advances presented at scientific meetings, including questions to ask your health care team, why access to new advances may not be available right away, and how to get involved with cancer research. Read More >>
August 30, 2022 · Tzvia Bader
In this post, stage IV melanoma survivor Tzvia Bader shares what it was like navigating treatment decision-making, how she became an active part of her care and found clinical trials to participate in, and her advice for other people with cancer on doing the same. Read More >>
August 10, 2022 · Christopher Flowers, MD, MS, FASCO; Vicki Keedy, MD; Daniel Mulrooney, MD, MS; and Sumanta (Monty) Pal, MD, FASCO
In this post, several experts describe the importance of peer-reviewed cancer information, including what “peer reviewed” means, what to know about levels of scientific evidence in cancer research, and the differences between research done in cell lines, animals, and humans. Read More >>
June 15, 2022 · Brielle Gregory Collins, ASCO staff
In this podcast, experts discuss what people with early-stage lung cancer should know about molecular testing, including what it is, how it may be used in guiding treatment decisions, and several recent studies about its role in treatment planning. Read More >>

Pages